Other

Virginia Commonwealth University

Hydra Biosciences, Inc.

Temple University

Organix, Inc.

Anu Mahadevan

Jayhong A Chong

Peter C Meltzer

Glenn R Larsen

Dennis John Underwood

Christopher Fanger

Amy Ripka

Magdalene M Moran

Manfred Weigele

Xiaoguang Zhen

Billy R Martin

Raj K Razdan

William C Lumma

David Baker

Mohamad I Damaj

Martin W Adler

Ronald F Tuma

Ming Zhang

A method is provided for treating a patient in need of therapy for central nervous system inflammation comprising administering to that patient a therapeutically effective amount of a cannabinoid agonist having efficacy at the CBreceptor but having substantially no efficacy at the CBreceptor at that amount.

Inflammation therapy

The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

Compounds for modulating TRPV3 function

The present application relates to compounds of Formula I as defined herein, and methods for treating pain and other conditions related to TRPV3.

Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 function

The invention compounds and methods for the treatment of motor disorders. In particular, the invention provides eicosanoid analogs which are effective in ameliorating motor disorders such as spasticity caused by multiple sclerosis (MS).

Anti-spasticity of an eicosanoid analog

Pyrazole cannabinoid agonist and antagonists

Growing community of inventors

Woburn, MA, United States of America

Anu Mahadevan